Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that individualized treatment and lifestyle changes are important for managing menopause symptoms and health risks.

The document explains hair and nail biology, common hair loss conditions and treatments, oral and genital skin diseases, and the risks and treatments associated with squamous cell carcinoma.

Finasteride may decrease semen quality but not harm sperm production, and stopping the drug can improve semen quality; hyperprolactinemia can cause infertility but is treatable with medication.

Testosterone therapy improved symptoms in a woman with congenital adrenal hyperplasia.

Menopause is a clear hormonal transition in women, while men experience a gradual testosterone decline, with some needing lifestyle changes and targeted therapy.

Diagnosing sex development disorders requires combining medical history, physical exams, imaging, lab tests, and genetic data.

Critical illness can lead to long-lasting physical and psychological problems, requiring ongoing, specialized care and rehabilitation.

The document suggests that finasteride may cause depression and suicidal thoughts, while prostate surgery does not harm sexual health.

The document concludes that treating skin conditions should include psychological care and a multidisciplinary approach is essential for effective management.

Testosterone therapy can help with androgen deficiency in women but should be used with caution and monitoring due to potential risks.

Hormonal imbalances can cause skin and hair problems in women, and treatments that block male hormones can help.

Finasteride for hair loss may cause erectile dysfunction due to tissue fibrosis, and various factors contribute to female sexual dysfunction.

Finasteride for hair loss doesn't harm erectile function; weight loss and exercise improve it.

Older patients with Cushing's syndrome often have different symptoms and treatment outcomes compared to younger patients.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Lower doses of treatments for hirsutism and acne in PCOS are effective and cause fewer side effects.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

The document suggests creating a validated score to diagnose Cushing's Syndrome and considers plasma steroid profiling as a simpler diagnostic method.

Women with PCOS often have mood disorders and a lower quality of life, and treatment should focus on both physical and mental health.

Finasteride treats enlarged prostate, improves urinary flow, but may cause sexual side effects.

Using steroids can increase the risk of heart problems.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

Some skin problems can be signs of diabetes or other metabolic diseases and recognizing them can help diagnose and treat these diseases early.

5α-reductase inhibitors may worsen sexual drive and spontaneous erections but don't worsen existing erectile or ejaculatory problems.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

Hair mesotherapy might help with certain types of hair loss but lacks strong scientific proof and has some risks.

The document concludes that better research methods are needed in men's sexual health to provide stronger evidence and improve patient care.

Early treatment and weight management are important for teenagers with PCOS to reduce symptoms and long-term health risks.

Many males in Jordan misuse oral contraceptive pills for hair growth, muscle gain, and acne treatment.